In this podcast, Peter Reaven, MD, discusses the effects of glucose variability on vascular disease outcomes, the results of the ACCORD and VADT trials, and how the trials' results have impacted clinical practice over the years. More at: www.consultant360.com/cardiology.

Peter Reaven, MD, on Glucose Variability and Vascular Disease Outcomes

Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.

Share Peter Reaven, MD, on Glucose Variability and Vascular Disease Outcomes

Sign up to save your podcasts

Peter Reaven, MD, on Glucose Variability and Vascular Disease Outcomes

Peter Reaven, MD, on Glucose Variability and Vascular Disease Outcomes

More shows like Podcasts360

The Curbsiders Internal Medicine Podcast